| Clinical Topic |
Measure # |
Measure Name |
Measure Description |
Owner |
Claims? |
| Diabetes Mellitus |
|
|
|
|
|
DM-1 |
HbA1c Management: Testing |
The percentage of patients 18-75 years of age with diabetes (type 1 or type 2) who
had Hemoglobin A1c (HbA1c) testing |
NCQA |
Yes |
|
DM-2 |
HbA1c Management: Poor Control |
The percentage of patients 18-75 years of age with diabetes (type 1 or type 2) who
had HbA1c in poor control (>9.0%) |
NCQA |
|
|
DM-3 |
Blood Pressure Management |
The percentage of patients 18-75 years of age with diabetes (type 1 or type 2) who
had a blood pressure <140/80 mmHg |
NCQA |
|
|
DM-4 |
Lipid Management: Testing |
The percentage of patients 18-75 years of age with diabetes (type 1 or type 2) who
had LDL-C screening performed |
NCQA |
Yes |
|
DM-5 |
Lipid Management: Control (<100 mg/dL) |
The percentage of patients 18-75 years of age with diabetes (type 1 or type 2) who
had LDL-C testing <100 mg/dL |
NCQA |
|
|
DM-6 |
Urine Protein Testing |
The percentage of patients 18-75 years of age with diabetes (type 1 or type 2) who
had medical attention for nephropathy |
NCQA |
Yes |
|
DM-7 |
Eye Examination |
The percentage of patients 18-75 years of age with diabetes (type 1 or type 2) who
had an eye exam (retinal) performed |
NCQA |
Yes |
|
DM-8
|
Foot Examination |
The percentage of patients 18-75 years of age with diabetes (type 1 or type 2) who
had a foot exam (visual inspection, sensory exam with monofilament, or pulse exam)
|
NCQA |
|
| Heart Failure |
|
|
|
|
|
HF-1 |
Left Ventricular Function (LVF) Assessment |
Percentage of patients with quantitative or qualitative results for LVF assessment
|
AMA |
|
|
HF-2 |
LVF Testing |
Percentage of patients with LVF testing during the current year for patients hospitalized
with a principal diagnosis of HF during the measurement period |
CMS |
Yes |
|
HF-3 |
Weight Measurement |
Percentage of patient visits with weight measurement recorded |
AMA |
|
|
HF-5 |
Patient Education |
Percentage of patients who were provided with patient education on disease management
and health behavior changes during one or more visit(s) |
AMA |
|
|
HF-6 |
Beta-Blocker Therapy |
Percentage of patients who were prescribed beta-blocker therapy |
AMA |
|
|
HF-7 |
ACE Inhibitor/ARB Therapy |
Percentage of patients who were prescribed ACE Inhibitor or ARB therapy
|
AMA |
|
|
HF-8 |
Warfarin Therapy for Patients with Atrial Fibrillation |
Percentage of patients with paroxysmal or chronic atrial fibrillation who were prescribed
warfarin therapy |
AMA |
|
| Coronary Artery Disease
|
|
|
|
|
|
CAD-1 |
Antiplatelet Therapy |
Percentage of patients with CAD who were prescribed antiplatelet therapy |
AMA |
|
|
CAD-2 |
Drug Therapy for Lowering LDL Cholesterol |
Percentage of patients who were prescribed a lipid-lowering therapy (based on ACC/AHA
guidelines) |
AMA |
|
|
CAD-3 |
Beta-Blocker Therapy-Prior Myocardial Infarction (MI) |
Percentage of patients with prior MI at any time who were prescribed beta-blocker
therapy |
AMA |
|
|
CAD-5 |
Lipid Profile |
Percentage of patients who received at least one lipid profile (or ALL component
tests) |
AMA |
Yes |
|
CAD-6 |
LDL Cholesterol Level |
Percentage of patients with most recent LDL cholesterol <100mg/dl |
CMS |
|
|
CAD-7 |
ACE Inhibitor or ARB Therapy |
Percentage of CAD patients who also have diabetes and/or LVSD who were prescribed
ACE Inhibitor or ARB therapy |
AMA |
|
| Preventive Care |
|
|
|
|
|
PC-1 |
Blood Pressure Management |
Percentage of patient visits with blood pressure (BP) measurement recorded |
AMA |
|
|
PC-5 |
Breast Cancer Screening |
Percentage of women 40-69 years of age who had a mammogram to screen for breast
cancer |
NCQA |
Yes |
|
PC-6 |
Colorectal Cancer Screening |
Percentage of patients screened for colorectal cancer during the one-year measurement
period |
AMA |
|
|
PC-7 |
Influenza Vaccination |
Percentage of patients who received an influenza vaccination during the one-year
measurement period |
AMA |
|
|
PC-8 |
Pneumonia Vaccination |
The percentage of patients 65 years or older who ever received a pneumococcal vaccination
|
NCQA |
|